Archford Capital Strategies’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-15
| Closed | -$1K | – | 630 |
|
2018
Q2 | $1K | Hold |
15
| – | – | ﹤0.01% | 637 |
|
2018
Q1 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 587 |
|
2017
Q2 | – | Sell |
-15
| Closed | – | – | 468 |
|
2017
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 747 |
|
2016
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 711 |
|
2016
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 692 |
|
2016
Q2 | $0 | Buy |
+15
| New | – | ﹤0.01% | 731 |
|
2016
Q1 | – | Sell |
-15
| Closed | -$1K | – | 441 |
|
2015
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 772 |
|
2015
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 636 |
|
2015
Q2 | $1K | Hold |
15
| – | – | ﹤0.01% | 604 |
|
2015
Q1 | $531 | Hold |
15
| – | – | ﹤0.01% | 690 |
|
2014
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 628 |
|
2014
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 626 |
|
2014
Q2 | $583 | Hold |
15
| – | – | ﹤0.01% | 840 |
|
2014
Q1 | $513 | Buy |
+15
| New | +$513 | ﹤0.01% | 804 |
|